$187.63+31.99% · 3M
Moving avg
1W+4.23%
1M+19.63%
3M+30.29%
6M+71.40%
YTD+69.46%
1Y+106.01%
3Y+154.21%
5Y+281.52%
52-week range
$73.16100% of range$161.53
Company health
Value0/6
Growth6/6
Profitability1/6
Health4/6
Dividend0/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- Revenue compounding 24% a year
Risks
- Trades 14% above the average analyst target
- Currently unprofitable
- Burning free cash flow
Key statistics
Valuation
Market cap
$11.07B
Enterprise value
$9.07B
P/E ratio (TTM)
-47.08x
P/S ratio (TTM)
16.45x
EV/EBITDA
-62.97x
Per share & returns
EPS (TTM)
-$3.26
Dividend yield
0.00%
Beta (1Y)
0.75
30-day change
+19.63%
Trading
Volume (24h)
177.44K
Previous close
$186.63
Shares outstanding
58.98M
About Glaukos Corporation
Sector
Healthcare
Industry
Medical - Devices
Exchange
NYSE
Symbol
GKOS
Glaukos Corporation is a large-cap healthcare company in the Medical - Devices industry. Its shares are listed on NYSE (United States) and trade under the ticker GKOS.
Frequently asked questions
What is Glaukos Corporation's market cap?
Glaukos Corporation (GKOS) has a market capitalization of $11.07B.
What sector is Glaukos Corporation in?
Glaukos Corporation operates in the Healthcare sector, Medical - Devices industry.
What exchange does GKOS trade on?
GKOS trades on NYSE.
Appears in
Eli Lilly and CompanyLLY
$1,215.75-0.37%
$1.14T cap
Johnson & JohnsonJNJ
$261.27+0.16%
$629.63B cap
AbbVie Inc.ABBV
$250.22+0.59%
$442.09B cap
UnitedHealth Group IncorporatedUNH
$402.23-0.83%
$365.28B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$354.73B cap
Merck & Co., Inc.MRK
$134.76+1.38%
$332.83B cap
Novartis AGSWX: NOVN
CHF 123.74-0.37%
$289.30B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.01B cap